To assess whether C/EBPδ may act as a tumor suppressor in pancreatic cancer, we first analyzed CEBPD mRNA expression levels in pancreatic ductal adenocarcinomas and in adjacent control tissue in publicly available gene expression datasets (GSE62452 [33] and GSE16515 [34]). This evidence concerns the gene CEBPD and neoplasm.